GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (CHIX:NSISBc) » Definitions » Shiller PE Ratio

Novonesis (Novozymes) B (CHIX:NSISBC) Shiller PE Ratio : 37.21 (As of Jul. 13, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Novonesis (Novozymes) B Shiller PE Ratio?

As of today (2025-07-13), Novonesis (Novozymes) B's current share price is kr453.20. Novonesis (Novozymes) B's E10 for the quarter that ended in Mar. 2025 was kr12.18. Novonesis (Novozymes) B's Shiller PE Ratio for today is 37.21.

The historical rank and industry rank for Novonesis (Novozymes) B's Shiller PE Ratio or its related term are showing as below:

CHIX:NSISBc' s Shiller PE Ratio Range Over the Past 10 Years
Min: 24.11   Med: 39.19   Max: 55.27
Current: 37.1

During the past years, Novonesis (Novozymes) B's highest Shiller PE Ratio was 55.27. The lowest was 24.11. And the median was 39.19.

CHIX:NSISBc's Shiller PE Ratio is ranked worse than
71.68% of 978 companies
in the Chemicals industry
Industry Median: 20.61 vs CHIX:NSISBc: 37.10

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted earnings per share data for the three months ended in Mar. 2025 was kr2.983. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is kr12.18 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novonesis (Novozymes) B Shiller PE Ratio Historical Data

The historical data trend for Novonesis (Novozymes) B's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Shiller PE Ratio Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.38 54.32 31.02 30.85 33.88

Novonesis (Novozymes) B Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.85 33.75 35.99 33.88 32.79

Competitive Comparison of Novonesis (Novozymes) B's Shiller PE Ratio

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Shiller PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Shiller PE Ratio falls into.


;
;

Novonesis (Novozymes) B Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novonesis (Novozymes) B's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=453.20/12.18
=37.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Novonesis (Novozymes) B's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.983/120.2000*120.2000
=2.983

Current CPI (Mar. 2025) = 120.2000.

Novonesis (Novozymes) B Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 2.268 100.200 2.721
201506 2.199 100.300 2.635
201509 2.409 100.200 2.890
201512 2.246 99.800 2.705
201603 2.432 100.200 2.917
201606 2.460 100.600 2.939
201609 2.479 100.200 2.974
201612 2.704 100.300 3.240
201703 2.580 101.200 3.064
201706 2.471 101.200 2.935
201709 2.770 101.800 3.271
201712 2.651 101.300 3.146
201803 2.726 101.700 3.222
201806 2.649 102.300 3.113
201809 2.757 102.400 3.236
201812 2.879 102.100 3.389
201903 2.407 102.900 2.812
201906 3.123 102.900 3.648
201909 2.230 102.900 2.605
201912 3.244 102.900 3.789
202003 2.883 103.300 3.355
202006 2.280 103.200 2.656
202009 2.527 103.500 2.935
202012 2.334 103.400 2.713
202103 3.150 104.300 3.630
202106 2.830 105.000 3.240
202109 3.011 105.800 3.421
202112 2.237 106.600 2.522
202203 2.980 109.900 3.259
202206 2.901 113.600 3.070
202209 4.143 116.400 4.278
202212 3.156 115.900 3.273
202303 2.818 117.300 2.888
202306 2.179 116.400 2.250
202309 3.363 117.400 3.443
202312 5.888 116.700 6.065
202403 0.597 118.400 0.606
202406 0.448 118.500 0.454
202412 3.953 118.900 3.996
202503 2.983 120.200 2.983

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novonesis (Novozymes) B  (CHIX:NSISBc) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novonesis (Novozymes) B Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines